| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;115:2376-2378.)
© 2007 American Heart Association, Inc.
Editorial |
From the Division of Cardiology (D.M.), Columbia University, New York, NY, and the Division of Cardiology (T.H.L.), Tulane University Medical School, New Orleans, La.
Correspondence to Donna Mancini, MD, Columbia Presbyterian Medical Center, 622 West 168th St, New York, NY 10032. E-mail dmm31@columbia.edu
Key Words: Editorials exercise heart failure
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
Since the 1980s, cardiopulmonary exercise testing has been applied to patients with congestive heart failure (CHF) to objectively assess exercise capacity, to risk stratify patients, and to assess the response to therapeutic interventions.1 Subsequently, peak oxygen consumption (
O2) was reported to be a reliable prognostic index and to be particularly useful for the timing of cardiac transplantation in patients with advanced CHF caused by left ventricular systolic dysfunction.2 As peak
O2 is derived from the Fick equation and as most patients achieve comparable arterial-venous oxygen differences when they give maximal effort, peak
O2 has provided a noninvasive marker for peak cardiac output response and thus cardiac reserve. However, peak
O2 is affected not only by the cardiac output response to exercise as observed in healthy subjects but also by limited skeletal muscle mass and perfusion in patients with advanced CHF. Thus the usefulness of peak
O2 to predict prognosis in patients with CHF also results from an objective quantification of the derangements that the failing heart causes in the periphery. Not unexpectedly, CHF patients with severe skeletal muscle wasting and low peak
O2 have a worse prognosis than patients with little or no muscle wasting and moderately reduced peak
O2. Numerous studies before and after the advent of ß-blocker therapy have repeatedly demonstrated the effectiveness of peak
O2 to predict outcome in patients with heart failure.35 The prognostic power of ancillary data collected during cardiopulmonary testing, such as
O2 at anaerobic threshold, percentage predicted peak
O2 and
This article has been cited by other articles:
![]() |
C. C. Lang, P. Karlin, J. Haythe, T. K. Lim, and D. M. Mancini Peak Cardiac Power Output, Measured Noninvasively, Is a Powerful Predictor of Outcome in Chronic Heart Failure Circ Heart Fail, January 1, 2009; 2(1): 33 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
Can Ventilatory Efficiency Be Used to Classify Patients with Heart Failure? Journal Watch Cardiology, June 6, 2007; 2007(606): 3 - 3. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |